Wockhardt slips after poor Q4 numbers

Wockhardt fell 3.35% to Rs 676.15 at 9:52 IST on BSE after consolidated net profit fell 77.76% to Rs 74.45 crore on 27.97% decline in total income to Rs 1059.67 crore in Q4 March 2014 over Q4 March 2013.

The result was announced after market hours on Monday, 26 May 2014.

Meanwhile, the BSE Sensex was down 157.63 points, or 0.64%, to 24,559.25.

On BSE, so far 1.79 lakh shares were traded in the counter, compared with an average volume of 5.36 lakh shares in the past one quarter.

The stock hit a high of Rs 686.25 and a low of Rs 641 so far during the day. The stock hit a 52-week high of Rs 1,325 on 27 May 2013. The stock hit a 52-week low of Rs 336.60 on 16 December 2013.

The stock had outperformed the market over the past one month till 23 May 2014, rising 8.87% compared with 7.94% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 71.83% as against Sensex's 19.29% rise.

The mid-cap company has an equity capital of Rs 54.88 crore. Face value per share is Rs 5.

On a consolidated basis, Wockhardt's net profit fell 47.26% to Rs 840.71 crore on 12.75% decline in total income to Rs 4914.64 crore in the year ended March 2014 over the year ended March 2013.

Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes. It has three research centres globally and manufacturing facilities across India, USA, UK and Ireland. The company has a significant presence in USA, Europe and India.

Powered by Capital Market - Live News